Table 3A.
Univariate RFS Analysis Result for Primary Tumors
| Variable | N | Progression No. | 5-Year RFS Rate (95% CI) | Hazard Ratio (95% CI) | P Value⁎ |
|---|---|---|---|---|---|
| All primary patients | 24 | 17 | 24.3% (8.9-43.8%) | ||
| Age at diagnosis | 1.04 (1-1.09) | .05 | |||
| FIGO stage | |||||
| I | 14 | 8 | 34.6% (10.1-61.1%) | Ref. level | .02 |
| II/III/IV | 10 | 9 | 10% (0.6-35.8%) | 3.11 (1.13-8.58) | |
| Clade | |||||
| Clade 1 | 9 | 8 | 11.1% (0.6-38.8%) | Ref. level | .02 |
| Clade 2 | 15 | 9 | 32.1% (9.5-57.9%) | 0.33 (0.12-0.86) | |
| Size | |||||
| ≤ 10 cm | 13 | 10 | 15.4% (1.2-45.3%) | Ref. level | .71 |
| > 10 cm | 11 | 7 | 30% (7.1-57.8%) | 1.2 (0.45-3.22) | |
| Mitotic index (five missing) | |||||
| ≤ 20 | 13 | 7 | 46.2% (19.2-69.6%) | Ref. level | .38 |
| > 20 | 6 | 5 | NR | 1.66 (0.52-5.28) |
Abbreviation: CI, Confidence interval.
⁎
P values were obtained by using Wald test based on Cox proportional hazards model for “age at diagnosis” and the log-rank test for the other variables.